Amendment No. 1 to Owner-Construction Manager Agreement between Advancis Pharmaceutical Corporation and Skanska USA Building, Inc.
Contract Categories:
Business Operations
›
Development Agreements
Summary
This amendment updates the agreement between Advancis Pharmaceutical Corporation and Skanska USA Building, Inc. (formerly Barclay White Skanska, Inc.) for construction work at Seneca Meadows, Gaithersburg, Maryland. It sets a guaranteed maximum price of $7,279,555 for the project, including an owner contingency, and establishes completion dates for different project phases. The amendment references specific contract documents and drawings that define the scope of work. Both parties have agreed to these terms and signed the amendment, confirming the new price and schedule.
EX-10.27 9 w88581a1exv10w27.txt AMENDMENT NO. 1 DATED 8/7/03 AGREEMENT Exhibit 10.27 /s/ /s/ ADVANCIS PHARMACEUTICAL BARCLAY WHITE SKANSKA INC CORPORATION DATE 3/27/03 DATE 4/7/03 -------------------------------- ------------------------------- ATTEST ATTEST /s/ Steven Shallcross /s/ -------------------------------- ------------------------------------ - -------------------------------------------------------------------------------- Amendment No. 1 to Agreement Between Owner and Construction Manager - -------------------------------------------------------------------------------- Pursuant to Paragraph 2.2 of the Agreement, dated July 12, 2002, between Advancis Pharmaceutical Corporation (Owner) and Skanska USA Building, Inc., successor by merger with Barclay White Skanska, Inc., (Construction Manager), for the construction of tenant improvements for Lot 4. Seneca Meadows, Gaithersburg, Maryland (the Project), the Owner and Construction Manager establish a Guaranteed Maximum Price and Contract Time for the Work as set forth below. ARTICLE 1 GUARANTEED MAXIMUM PRICE The Construction Manager's Guaranteed Maximum Price for the Work, including the estimated Cost of the Work as defined in Article 6 and the Construction Manager's Fee as defined in Article 5, is Seven Million, Two Hundred Seventy-Nine Thousand, Five Hundred and Fifty-Five Dollars ($7,279,555.00). The sum of $335,734 is included in the Guaranteed Maximum Price as Owner contingency. This Price is for the performance of the Work in accordance with the Contract Documents listed and attached to this Amendment and marked Exhibits A through F, as follows: Exhibit A Drawings, Specifications, addenda and General, Supplementary and other Conditions of the Contract on which the Guaranteed Maximum Price is based, pages 1 through 12 dated January 7, 2003. Exhibit B Allowance items, pages 1 dated January 9, 2003. Exhibit C Clarifications made in preparing the Guaranteed Maximum Price, pages 1, dated January 9, 2003. Exhibit D Completion schedule, pages 1 through 8, dated December 20, 2002. Exhibit E Alternate prices, pages 1, dated January 9, 2003. (C) 1991 - THE AMERICAN INSTITUTE OF ARCHITECTS, 1735 NEW YORK AVENUE, N.W., WASHINGTON, D.C. 20006-5292 AIA DOCUMENT AIA121/CMC AND AGC DOCUMENT 565 - OWNER-CONSTRUCTION MANAGER AGREEMENT - 1991 EDITION - AIA(R)- AGC -(C)1991 - THE ASSOCIATED GENERAL CONTRACTORS OF AMERICA, 1957 E STREET, N.W., WASHINGTON, D.C. 20006-5209. WARNING: Unlicensed photocopying violates U.S. copyright laws and is subject to legal prosecution. This document was electronically produced with permission of the AIA and can be reproduced in accordance with your license without violation until the date of expiration as noted below, expiration as noted below. User Document: Advancis form a121 version 2.___ -- 3/21/2003. AIA License Number 1013483, which expires on 2/27/2004. Exhibit F None. Exhibit G Supplement to Insert 5.2.2. ARTICLE II CONTRACT TIME The date of Substantial Completion established by this Amendment is: Phase 1 administrative offices is April 29, 2003 and remainder of space is August 19, 2003. OWNER CONSTRUCTION MANAGER By: /s/ By: /s/ ADVANCIS PHARMACEUTICAL SKANSKA USA BUILDING, INC., CORPORATION DATE 3/27/03 DATE 4/7/03 --------------------------- ----------------------------- ATTEST /s/ Steven Shallcross ATTEST /s/ --------------------------- ------------------------------------ (C) 1991 - THE AMERICAN INSTITUTE OF ARCHITECTS, 1735 NEW YORK AVENUE, N.W., WASHINGTON, D.C. 20006-5292 AIA DOCUMENT AIA121/CMC AND AGC DOCUMENT 565 - OWNER-CONSTRUCTION MANAGER AGREEMENT - 1991 EDITION - AIA(R)- AGC -(C)1991 - THE ASSOCIATED GENERAL CONTRACTORS OF AMERICA, 1957 E STREET, N.W., WASHINGTON, D.C. 20006-5209. WARNING: Unlicensed photocopying violates U.S. copyright laws and is subject to legal prosecution. This document was electronically produced with permission of the AIA and can be reproduced in accordance with your license without violation until the date of expiration as noted below, expiration as noted below. User Document: Advancis form a121 version 2.___ -- 3/21/2003. AIA License Number 1013483, which expires on 2/27/2004. EXHIBIT A Current Drawing List Summary Log, Grouped by Type and Discipline - -------------------------------------------------------------------------------- Advancis Pharmaceutical Corporation Tenant Improvements Project # 152017 Advancis Pharmaceutical Corporation Tel: 301 ###-###-#### 20417 Goldenrod Lane Fax: 301 ###-###-#### Germantown, MD 20852 - --------------------------------------------------------------------------------
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT A (CONT.) Current Drawing List Summary Log, Grouped by Type and Discipline
EXHIBIT B ADVANCIS PHARMACEUTICAL CORPORATION SENECA MEADOWS, GERMANTOWN, MD 152017 SKANSKA USA BUILDING GMP PROPOSAL ALLOWANCES (REVISED) JANUARY 9, 2003 The following allowances are included in our GMP pricing:
EXHIBIT C ADVANCIS PHARMACEUTICAL CORPORATION SENECA MEADOWS, GERMANTOWN, MD 152017 SKANSKA USA BUILDING GMP PROPOSAL CLARIFICATIONS JANUARY 9, 2003 1. Skanska USA Building performance and payment bond costs are not included. 2. No landscaping costs are included. 3. Controls for process piping are not included. 4. We have included the sum of $18,600 in our GMP to provided sprinkler protection for the future expansion area. 5. Skylights are provided by Minkoff Development Corporation. 6. We have included the sum of $38,343 to provide the utility yard equipment screen. 7. Dock leveler pit to be provided by Minkoff. Leveler to be provided by Skanska USA Building. 8. The following items are not included in the GMP: - Kitchen appliances - AV system (other than satellite TV dish and 4 outlets) - Darkroom equipment - Security system - Warehouse racking - Signs and artwork - Teleconferencing - Reception furniture 9. Building permit costs are not included.
EXHIBIT E ADVANCIS PHARMACEUTICAL CORPORATION SENECA MEADOWS, GERMANTOWN, MD 152017 SKANSKA USA BUILDING GMP PROPOSAL ALTERNATES (REVISED) JANUARY 9, 2003 The following items are not included in the GMP:
*Per Schlenger/Pitz alternate not pursued. EXHIBIT G SUPPLEMENT TO INSERT 5.2.2 AGREEMENT DATED JULY 12, 2002 BETWEEN ADVANCIS PHARMACEUTICAL CORPORATION AND SKANSKA USA BUILDING INC. INCENTIVE FEE Insert 5.2.2 of the Agreement provides for the Construction Manager to have the opportunity to earn an incentive fee. The last sentence of Insert 5.2.2 states that "The amount of the incentive payment, the contingency amount and the savings amount shall be established at the time the Guaranteed Maximum Price is accepted by the Owner." The parties hereby establish those items as follows: 1. The maximum amount of incentive fee which the Construction Manager has the right to earn is $100,000.00. 2. The Guaranteed Maximum Price includes a construction contingency amount of $319,747.00 for use by the General Manager for the price increases not the responsibility of the Construction Manager. 3. The savings amount shall be the unspent portion of the contingency for savings from the part of the Construction Manager's Guaranteed Maximum Price representing the construction cost as specified in Insert 5.2.2. Insert 5.2.2 also states that the "Owner and Construction Manager will share savings and any unused amount of the contingency in a proportion established at such time as Owner accepts the Guaranteed Maximum Price." The parties hereby specify the allocation of the contingency as seventy-five percent (75%) to the Owner and twenty-five percent (25%) to the Construction Manager. An example of the allocation is as follows, assuming that the amount remaining in the contingency fund or available from other savings in the construction cost as specified in Insert 5.2.2 following completion of construction of the Project is $400,000:
The Guaranteed Maximum Price also includes a contingency of $335,734.00 for use solely by the Owner to cover changes to the Project desired by the Owner. The parties shall not include such amount, or any amount remaining of such contingency, in the contingency available for calculation of the Construction Manager's incentive fee. 1